Related Experiment Videos
Interaction of p53 with the adenovirus E1B-55 kDa protein
Judith Roth1, Matthias Dobbelstein
1Abteilung Gastroenterologie, Klinikum der Universität Marburg, Germany.
Abstract:
The E1B-55 kDa oncoprotein of adenovirus type 5 targets the tumor suppressor protein p53. This includes four distinct activities: (i) biochemical interaction of E1B-55 kDa with p53; (ii) inhibition of p53-induced transcription; (iii) relocalization of p53 from the nucleus to the cytoplasm; and (iv) in the simultaneous presence of E1B-55 kDa and the adenovirus E4-34 kDa (E4orf6) protein, extensive destabilization of p53. These activities can be observed experimentally, using co-immunoprecipitation of p53 with E1B-55 kDa, luciferase reporter assay of p53 activity, immunofluorescence to localize p53 and E1B-55 kDa, and immunoblot analysis of p53 levels. These experimental systems can be useful when analyzing novel interaction partners and modulators of p53, or in deciding whether adenovirus oncoproteins interact with novel growth regulatory proteins. Protocols describing the four methods are provided in this chapter.
Insights
Adenovirus oncoprotein E1B-55 kDa targets tumor suppressor p53 through interaction, transcriptional inhibition, and altered localization. Co-expression with E4orf6 protein destabilizes p53, offering insights into viral oncogenesis.
Area of Science:
- Molecular biology
- Virology
- Cancer research
Background:
- Adenovirus type 5 E1B-55 kDa oncoprotein is a key viral factor in oncogenesis.
- The tumor suppressor protein p53 plays a critical role in cellular defense against cancer.
- Understanding the interaction between viral oncoproteins and tumor suppressors is crucial for cancer research.
Purpose of the Study:
- To detail the multifaceted mechanisms by which adenovirus E1B-55 kDa targets p53.
- To describe experimental methods for observing these interactions and their consequences.
- To provide a framework for analyzing novel p53 interactions and adenovirus oncoprotein functions.
Main Methods:
- Co-immunoprecipitation to assess biochemical interaction between E1B-55 kDa and p53.
- Luciferase reporter assays to measure inhibition of p53-induced transcription.
- Immunofluorescence microscopy for p53 and E1B-55 kDa nuclear-cytoplasmic relocalization.
- Immunoblot analysis to quantify p53 protein levels and destabilization.
Main Results:
- Adenovirus E1B-55 kDa directly interacts with p53.
- E1B-55 kDa inhibits p53-mediated transcriptional activity.
- E1B-55 kDa induces the relocalization of p53 from the nucleus to the cytoplasm.
- Concomitant expression of E1B-55 kDa and E4orf6 leads to significant p53 destabilization.
Conclusions:
- Adenovirus E1B-55 kDa employs multiple strategies to inactivate the tumor suppressor p53.
- The described experimental systems are valuable for studying p53 regulation and viral oncoprotein activity.
- These findings contribute to understanding adenovirus-mediated oncogenesis and potential therapeutic targets.